13-cis-retinoic acid in the treatment of recurrent glioblastoma multiforme.
about
Retinoids in the treatment of glioma: a new perspective.Salvage therapy with single agent bendamustine for recurrent glioblastoma.Modulation of glioma risk and progression by dietary nutrients and antiinflammatory agents.Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma.Canadian recommendations for the treatment of glioblastoma multiforme.Chemotherapy for malignant glioma.Identification of retinol binding protein 1 promoter hypermethylation in isocitrate dehydrogenase 1 and 2 mutant gliomas.Use of high-dose chemotherapy in front-line therapy of childhood malignant glioma.Chemotherapy in the treatment of malignant gliomas.Inhibition of 13-cis retinoic acid-induced gene expression of reactive-resistance genes by thalidomide in glioblastoma tumours in vivoPreradiation chemotherapy may improve survival in pediatric diffuse intrinsic brainstem gliomas: final results of BSG 98 prospective trial.From the Cover: Neutralization of terminal differentiation in gliomagenesis.Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition.An algorithm for chemotherapy treatment of recurrent glioma patients after temozolomide failure in the general oncology setting.Isotretinoin maintenance therapy for glioblastoma: a retrospective review.The role of targeted therapies in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.Retinoic acid signaling and neuronal differentiation.Biochemical properties of retinoid-converting enzymes and biotechnological production of retinoids.Retinoid resistance and multifaceted impairment of retinoic acid synthesis in glioblastoma.Constitutive androstane receptor agonist CITCO inhibits growth and expansion of brain tumour stem cells.Retinol dehydrogenase-10 promotes development and progression of human glioma via the TWEAK-NF-κB axis.Evidence and Context of Use for Contrast Enhancement as a Surrogate of Disease Burden and Treatment Response in Malignant Glioma.Not every patient needs a triglyceride check, but all can get pancreatitis: a systematic review and clinical characterization of isotretinoin-associated pancreatitis.Ask the Experts: How best to treat recurrent glioma.Combination of metformin and 9-cis retinoic acid increases apoptosis in C6 glioma stem-like cells.
P2860
Q30464615-73409D1E-72CC-4A51-BCC4-7A46A76670E9Q33395579-B8682D35-8199-4EFA-93D9-89DF28F5EBCBQ34618239-AB13F79B-C4F5-4886-98B2-683E08119AE7Q34886836-ECABE5F9-8054-44D8-81DF-033F32EC935FQ35855352-3E3418D5-676D-4E0E-A6B4-04810FC3C465Q36307802-A8B359E6-ADB7-4FEF-8AA4-5D2419BE882FQ36486875-1E2518DD-9E4B-4E3F-969B-627B88C472ECQ36499230-E2DC4E6F-74E7-4F2C-BD9D-AFBB7C5FC54BQ36499238-FC202701-73BE-40AF-9B8D-62BBA8FFE78EQ36557180-3C78BA2C-0BA0-459B-B4A8-20C7BA0F29BEQ37151999-35A1B485-011E-4041-A2BC-CB41ED960926Q37157385-CA3FEFBE-50A3-46BF-ABE5-C29DF7D916D6Q37640483-A2A2E8DA-A29F-40F6-AFB4-3A112E082E8AQ37858468-3B56286F-D08C-43FE-9362-5A922D971804Q38107049-65A0A1A8-72CA-42A2-82DF-09B7C2351788Q38205134-A7F0182D-7304-4D56-90E9-B99E7DDF601FQ38307264-3C2316DA-2D8C-4972-A1FC-52136312E048Q38558416-833F3720-3B8F-4888-AA0A-606C10855E95Q40973364-3F613346-9166-4D4E-97E4-C8FE38AC79B3Q42653228-86450916-7D89-4E66-AE59-DF5A8880C036Q47108426-07BF3249-173B-4474-84F8-8D3F8325C68CQ47436703-660A00EE-F9B1-4065-AEFB-24026A7A0005Q48194486-4249F4D2-C835-42C5-AEC0-DF811AA3B561Q48394075-D418F8AD-0BA9-4CAD-9815-642D12E131BDQ55240863-FF65FF43-39B6-4757-AD77-C8EFA5EC777C
P2860
13-cis-retinoic acid in the treatment of recurrent glioblastoma multiforme.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
13-cis-retinoic acid in the treatment of recurrent glioblastoma multiforme.
@ast
13-cis-retinoic acid in the treatment of recurrent glioblastoma multiforme.
@en
type
label
13-cis-retinoic acid in the treatment of recurrent glioblastoma multiforme.
@ast
13-cis-retinoic acid in the treatment of recurrent glioblastoma multiforme.
@en
prefLabel
13-cis-retinoic acid in the treatment of recurrent glioblastoma multiforme.
@ast
13-cis-retinoic acid in the treatment of recurrent glioblastoma multiforme.
@en
P2093
P2860
P1433
P1476
13-cis-retinoic acid in the treatment of recurrent glioblastoma multiforme.
@en
P2093
Kenneth R Hess
Morris D Groves
Siew-Ju See
Victor A Levin
W-K Alfred Yung
P2860
P304
P356
10.1215/S1152851703000607
P577
2004-07-01T00:00:00Z